FPR2 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA533539-Each-of-1 | In Stock | ₹ 48,905.50 |
PIPA533539 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 48,905.50
GST (18%): ₹ 8,802.99
Total Price: ₹ 57,708.49
Antigen
FPR2
Classification
Polyclonal
Conjugate
Unconjugated
Gene
FPR2
Gene Alias
ALXR; E330010I07Rik; fMLPR1; FMLP-related receptor I; FMLP-R-I; FMLP-R-II; FMLPX; formyl peptide receptor 2; formyl peptide receptor, related sequence 2; formyl peptide receptor, related sequence 2-like; formyl peptide receptor-like 1; Formylpeptide receptor-related sequence 2; FPR2; FPR2A; FPRH1; FPRH2; Fprl1; Fprl-1; FPR-like 1; Fpr-rs1; Fpr-rs2; HM63; Lipoxin A4 receptor; lipoxin A4 receptor (formyl peptide receptor related); lipoxin A4 receptor-like protein; Lipoxin receptor; LXA4 receptor; LXA4R; N-formyl peptide receptor 2; N-formylpeptide receptor-like 2; RFP
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
2358
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Immunohistochemistry (Paraffin)
Concentration
1 mg/mL
Formulation
PBS with 0.1% sodium azide
Gene Accession No.
P25090
Gene Symbols
FPR2
Immunogen
Synthetic 18 amino acid peptide from N-terminal extracellular domain of human FPR2 / FPRL1.
Quantity
50 μg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla (100%) Orangutan, Monkey (94%) Marmoset, Rabbit (83%)
- Formyl peptide receptor 2 (FPR2) is a low affinity receptor for N-formyl-methionyl peptides
- Binding of FMLP to FPR2 causes activation of neutrophils
- The response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system
- The activation of LXA4R could result in an anti-inflammatory outcome counteracting the actions of proinflammatory signals such as LTB4.